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Introduction
Recent advances in contrast-enhanced MR angiography
(CE-MRA) at 3.0 T support highly accelerated parallel
acquisition for improved pulse sequence performance. In
clinical practice, CE-MRA of the supra-aortic arteries is
performed using 0.1–0.2 mmol/kg of gadolinium. Histor-
ically, this has been a very uncontroversial area, in view of
the excellent safety record of gadolinium contrast agents
and the assumed correlation between image quality and
contrast dose. However, recent reports linking gadolin-
ium-based contrast agents with nephrogenic systemic
fibrosis (NSF) in renal failure patients has focused atten-
tion on the importance of minimizing dose and (by
implication) risk in vulnerable patient subgroups.
Currently, no validated approach exists for the selection of
minimal or optimal contrast dosing for MR angiography
of the head and neck arteries at 3.0 T. Relative to high dose
or intermediate dose protocols at 3.0 T, low-dose contrast
infusion protocols may result in MR angiograms of diag-
nostic quality, while diminishing cost and the risk of
dose-dependent complications in susceptible popula-
tions.
Purpose
To prospectively compare the diagnostic image quality
resulting from three dose regimens for high-spatial resolu-
tion 3D contrast-enhanced MR angiography of supra-aor-
tic arteries at 3.0 T.
Methods
100 consecutive patients were randomized into three
groups (A, n = 40; B, n = 40; C, n = 20) and underwent 3D
high-spatial resolution CEMRA of supra-aortic arteries at
3.0 T (Trio, Siemens) using an identical acquisition proto-
col. A fast spoiled gradient-echo sequence with parallel
acquisition (GRAPPA × 4) generated 120 partitions (voxel
dimensions 0.7 × 0.7 × 0.8 mm3) in 21 seconds. The con-
trast injection protocols were 1) 25 mL, 2) 15 mL, 3) 7.5
mL of Magnevist (Berlex Laboratories, Wayne, NJ) at a rate
of 0.8, 0.5, and 0.25 mmol/sec, respectively. Supra-aortic
arterial territory was divided into 34 segments and
assessed for visibility of arterial segments, venous contam-
ination, and severity of stenosis (4-point scales) by two
readers. Signal-to-noise ratio (SNR) and contrast-to-noise
ratio (CNR) was also evaluated. Statistical analysis was
performed using Wilcoxon, ANOVA, and kappa test.
Results
Reader 1 and 2 identified arterial delineation as sufficient
for diagnosis or excellent in group A for 1311 (96.4%)
and 1313 (96.6%) segments, in group B for1321 (97.6%)
and 1319 (97.4%) segments, and in group C for 658
(97.5%) and 662 (98.1%) segments, respectively (good
inter-observer agreement). Reader 1(2) identified venous
contamination in 24 (21), 15 (11), and 11(9) segments,
and arterial stenosis in 52(48), 27 (25), and 31(29) seg-
ments in groups A, B, and C, respectively (excellent inter-
observer agreement). No significant difference existed
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between arterial delineation and venous contamination
scores for each reader between the three groups (P > 0.05).
SNR and CNR values were significantly lower in group C
compared to groups A and B.
Conclusion
High-spatial resolution CEMRA of the supra-aortic arter-
ies at 3.0 T can be performed with a gadolinium dose as
low as 0.05 mmol/kg without compromising image qual-
ity. Adoption of low-dose protocols should diminish sen-
sitivity to dose-dependent complications and result in
substantial cost savings.Page 2 of 2
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